The global protein expression market growth forecasted to transform from USD 3.41 billion in 2024 to USD 4.82 billion by 2029 ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported new ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

The FDA has approved Emrelis for the treatment of adult patients with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Most land plants form mutually beneficial symbioses with fungi. The plant and the fungus exchange vital nutrients. A team led ...

Transgenic chloroplasts offer unique advantages in plant biotechnology, including high-level foreign protein expression, absence of epigenetic effects, and gene containment due to the lack of ...

Scientists observe ribosomal cooperation that prevents pauses in protein synthesis, revealing new dynamics for cellular ...

Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized ...

The primary endpoint in ENDEAVOR is the change from baseline in the quantity of ELEVIDYS micro-dystrophin protein expression measured by western blot at 12 weeks. Secondary outcome measures ...